|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500103538 |
|
最近更新日期: Date of Last Refreshed on: |
2025-05-30 11:19:58 |
|
注册时间: Date of Registration: |
2025-05-30 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
正念减压疗法对早产儿母亲创伤后成长的效果研究 |
|
Public title: |
The Effectiveness of Mindfulness-Based Stress Reduction on Post-Traumatic Growth in Mothers of Preterm Infants |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
正念减压疗法对早产儿母亲创伤后成长的效果观察 |
|
Scientific title: |
The Effectiveness of Mindfulness-Based Stress Reduction on Post-Traumatic Growth in Mothers of Preterm Infants |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
邹纯净 |
研究负责人: |
邹纯净 |
|
Applicant: |
Zouchunjing |
Study leader: |
Zouchunjing |
|
申请注册联系人电话: Applicant telephone: |
+86 183 4311 5737 |
研究负责人电话: Study leader's telephone: |
+86 183 4311 5737 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
38298127@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
38298127@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
吉林省长春市朝阳区万宝街与西朝阳路 |
研究负责人通讯地址: |
吉林省长春市朝阳区万宝街与西朝阳路 |
|
Applicant address: |
Wanbao Street and Xichao Yang Road, Chaoyang District, Changchun City, Jilin Province |
Study leader's address: |
Wanbao Street and Xichao Yang Road, Chaoyang District, Changchun City, Jilin Province |
|
申请注册联系人邮政编码: Applicant postcode: |
130000 |
研究负责人邮政编码: Study leader's postcode: |
130000 |
|
申请人所在单位: |
吉林大学第一医院 |
||
|
Applicant's institution: |
The First Hospital of Jilin University |
||
|
研究负责人所在单位: |
吉林大学第一医院 |
||
|
Affiliation of the Leader: |
The First Hospital of Jilin University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
24K164-001 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
吉林大学第一医院伦理委员会 |
||
|
Name of the ethic committee: |
The Ethics Committee of the First Hospital of Jilin University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-07-09 00:00:00 |
||
|
伦理委员会联系人: |
郭迪 |
||
|
Contact Name of the ethic committee: |
Guodi |
||
|
伦理委员会联系地址: |
吉林省长春市新民大街1号 |
||
|
Contact Address of the ethic committee: |
1 Xinmin Dajie, Changchun City, Jilin Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 431 8878 2013 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
吉林大学第一医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The First Hospital of Jilin University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
吉林省长春市新民大街1号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
1 Xinmin Dajie, Changchun City, Jilin Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
研究生团队 |
||||||||||||||||||||||
|
Source(s) of funding: |
Graduate team |
||||||||||||||||||||||
|
Target disease: |
Psychology of preterm mother |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
I期临床试验 | ||||||||||||||||||||||
|
Study phase: |
1 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
构建适用于早产儿母亲的正念减压干预方案,系统探讨正念减压疗法对早产儿母亲创伤后成长水平、焦虑、抑郁及压力水平的干预效果。 |
||||||||||||||||||||||
|
Objectives of Study: |
To develop a Mindfulness-Based Stress Reduction (MBSR) intervention protocol for mothers of premature infants and systematically explore its effects on their Post-Traumatic Growth (PTG), anxiety, depression, and stress levels. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.胎龄<37周,入住NICU的早产儿母亲 2.无早产史,无慢性精神疾病史,未服用抗焦虑和抗抑郁药,未接受心理治疗 3.早产儿母亲无交流障碍,能理解问卷调查的内容 4.知情同意,自愿参加研究 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Mothers of premature infants with gestational age < 37 weeks and admitted to the NICU 2. No history of preterm birth, no history of chronic mental illness, no taking anxiolytic and antidepressant drugs, and no psychotherapy 3. The mother of premature infants has no communication barrier and can understand the content of the questionnaire 4. Informed consent, voluntary participation in the study |
||||||||||||||||||||||
|
排除标准: |
1.在研究结束前早产儿转院、放弃治疗或者死亡 2.早产儿母亲中止或不愿参加本研究 3.经PHQ-9量表评分≥10分,即中度以上产后抑郁的早产儿母亲 4.患有先天性疾病或研究期间手术的早产儿的母亲 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. The premature infant was transferred to the hospital, abandoned treatment, or died before the end of the study 2. Mothers of preterm infants discontinue or are unwilling to participate in this study 3. Mothers of preterm infants with a score of ≥ 10 points on the PHQ-9 scale, that is, moderate or above postpartum depression 4. Mothers of preterm infants with congenital diseases or surgery during the study |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-05-01 00:00:00至 To 2025-05-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2024-07-10 00:00:00 至 To 2025-01-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
随机化分组:产生随机序列 利用Excel软件产生的随机数实现随机分组。要收集54名早产儿母亲,随机分成2组,首先在Excel随机生成54个随机数字1-54,将随机数字进行自上而下的编号1-54号, 随机数字为奇数进入对照组,随机数字为偶数进入干预组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Randomized grouping: Generates a random sequence The random number generated by Excel software is used to realize random grouping. Fifty-four mothers of preterm infants were collected and randomly divided into two groups. First, 54 random numbers 1-54 were generated randomly in Excel and numbered 1-54 from top to bottom. Odd numbers entered the control group and even numbers entered the intervention group. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
无 |
|
Blinding: |
none |
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
填写原始数据的方式,2025年7月1日以后,用38298127@qq.com邮箱。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
To fill in the original data, use 38298127@qq.com after July 1, 2025. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
电子采集与管理系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Electronic acquisition and management system |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |